Medicine Man Technologies, Inc. (SHWZ)

Medicine Man Technologies Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-34.55	-18.47	14.52	-19.42	-16.98
Depreciation & Amortization	20.26	11.01	8.58	0.48	0.06
Share-Based Compensation	3.59	0.81	5.04	8.23	7.18
Other Operating Activities	22.9	18.04	29.2	0.91	2.18
Operating Cash Flow	12.2	11.39	57.33	-9.8	-7.55
Operating Cash Flow Growth	7.08%	-80.13%	-	-	-
Capital Expenditures	-10.62	-14.81	-5.67	-0.77	-0.2
Acquisitions	-15.83	-62.37	-75.68	-33.28	0
Change in Investments	-	-4	-	-	-
Other Investing Activities	0.01	2	0.18	0.83	-0.92
Investing Cash Flow	-26.44	-79.18	-81.16	-33.22	-1.12
Common Stock Issued	18.8	0.47	50.28	12.63	19.6
Share Repurchases	-0.11	0	0	0	0
Other Financing Activities	-24.37	-0.13	78.72	19.28	0.6
Financing Cash Flow	-5.46	0.34	129	31.9	20.2
Net Cash Flow	-19.7	-67.45	105.17	-11.12	11.53
Free Cash Flow	1.59	-3.42	51.67	-10.57	-7.75
Free Cash Flow Margin	0.92%	-2.14%	47.65%	-44.03%	-73.03%
Free Cash Flow Per Share	0.02	-0.06	0.51	-0.26	-0.23

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.